Literature DB >> 20441235

Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.

Karin Knesaurek1, Josef Machac, M Muzinic, Michael DaCosta, Zhuangyu Zhang, Sherif Heiba.   

Abstract

Yttrium-90 ((90)Y)-microspheres administered via the hepatic artery has been used for the treatment of unresectable primary or metastatic cancer in the liver. Prior to (90)Y therapy, however, the (90)Y administered activity and the percent shunting to lungs must be determined, most commonly by gamma camera imaging of technetium-99m ((99m)Tc)-macroaggregated albumin (MAA). The purpose of the current study was to identify and evaluate an objective measure of the correlation of (90)Y and MAA activity distributions and thus assess the reliability of MAA imaging for evaluation of (90)Y administered activity and tumor and liver radiation doses. The MAA study consisted of two acquisitions. After administration of 185 MBq of MAA, a partial-body or so-called breakthrough scan was performed in order to determine the percent shunting to lungs. Immediately after a breakthrough scan, a combined single-photon emission computed tomography (SPECT)/transmission computed tomography (CT) scanner was used to image MAA distribution in order to derived the prescribed (90)Y administered activity based on tumor and liver dosimetry. (90)Y SPECT/CT was performed 2-4 weeks later and activities used were in the range of 777-2,442 MBq. In order to compare (90)Y and MAA SPECT images, first the respective CT image sets were registered using a transform based on normalized mutual information. The transform thus derived was used to align the 90Y and MAA SPECT image sets, and the Spearman's (rho) rank correlation as well as image distance (L2-norm) between the registered SPECT images were then calculated. The Spearman's rank correlation values ranged from 0.451 to 0.818 and the L2 distances from 0.626 to 2.889. Based on visual inspection, the registration of the (90)Y and MAA SPECT images appeared reasonably accurate. The regression coefficient (r) between visual scoring and the Spearman's rank correlation was 0.65 and between visual scoring and L2 distance 0.61. The Spearman's rank correlation thus appears to be more reliable than the image distance for assessing the correlation of the (90)Y and MAA images.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441235     DOI: 10.1177/153303461000900304

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  29 in total

Review 1.  Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

Authors:  Stephan Walrand; Glenn D Flux; Mark W Konijnenberg; Roelf Valkema; Eric P Krenning; Renaud Lhommel; Stanislas Pauwels; Francois Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-11       Impact factor: 9.236

Review 2.  The role of SPECT/CT in radioembolization of liver tumours.

Authors:  Hojjat Ahmadzadehfar; Heying Duan; Alexander R Haug; Stephan Walrand; Martha Hoffmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-18       Impact factor: 9.236

3.  Assessing Spatial Concordance Between Theranostic Pairs Using Phantom and Patient-Specific Acceptance Criteria: Application to 99mTc-MAA SPECT/90Y-Microsphere PET.

Authors:  Justin K Mikell; Bill S Majdalany; Dawn Owen; Kelly C Paradis; Yuni K Dewaraja
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-22       Impact factor: 7.038

4.  166Ho microsphere scout dose for more accurate radioembolization treatment planning.

Authors:  C Chiesa; M Maccauro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04       Impact factor: 9.236

5.  Tumour-to-normal tissue (T/N) dosimetry ratios role in assessment of 90Y selective internal radiation therapy (SIRT).

Authors:  Karin Knešaurek; Ricardo Bello Martinez; Munir Ghesani
Journal:  Br J Radiol       Date:  2021-11-26       Impact factor: 3.039

6.  Application of albumin-based nanoparticles in the management of cancer.

Authors:  Xinzhe Yu; Chen Jin
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

7.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

8.  Semi-Quantitative Analysis of Post-Transarterial Radioembolization (90)Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With (99m)Tc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT).

Authors:  Seunghong Rhee; Sungeun Kim; Jaehyuk Cho; Jukyung Park; Jae Seon Eo; Soyeon Park; Eunsub Lee; Yun Hwan Kim; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2015-09-14

Review 9.  Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.

Authors:  Riad Salem; Vincenzo Mazzaferro; Bruno Sangro
Journal:  Hepatology       Date:  2013-10-04       Impact factor: 17.425

10.  Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation.

Authors:  Jae Seon Eo; Jin Chul Paeng; Dong Soo Lee
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.